Premium
Intracorporal Injection of Papaverine and Phentolamine in the Management of Impotence
Author(s) -
ROBINETTE M. A.,
MOFFAT M. J.
Publication year - 1986
Publication title -
british journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 0007-1331
DOI - 10.1111/j.1464-410x.1986.tb05914.x
Subject(s) - phentolamine , papaverine , medicine , incidence (geometry) , anesthesia , surgery , erectile dysfunction , physics , optics , propranolol
Summary— Intracorporal injection of 0.5 ml papaverine (30 mg/ml) and phentolamine (2.5 mg/ml) was given to 144 patients presenting with various types of impotence. The high response rate (97%) precluded the use of this test to differentiate between types of impotence but provided patients with the choice of embarking on a self‐injection programme. Of the 101 patients entering the programme, 78 are continuing self‐injection therapy with a mean follow‐up of 6.5 months. The incidence of complications is low and patients are generally very satisfied with the treatment.